SCICLONE PHARMACEUTICALS INC Financial and Nonfinancial Liabilities, Fair Value Disclosure
SCICLONE PHARMACEUTICALS INC had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $562.00 thousand as of 2012-09-30, per its 10-Q/A filed 2013-04-01.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2013-04-01
- 2012-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $562.00K.
- 2012-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $13.32M.
- 2011-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $15.40M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2012-09-30 | $562.00K 10-Q/A · filed 2013-04-01 |
| 2012-06-30 | $13.32M 10-Q/A · filed 2013-04-01 |
| 2011-12-31 | $15.40M 10-K · filed 2013-04-01 |